Angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers vs. calcium channel blockers for 12,478 young hypertensive patients under 40 in 10-year follow-up

被引：0
|
作者：
Jo, S. H. [1 ]
Shim, H. S. [2 ]
Hong, J. Y. [1 ]
Kim, T. H. [2 ]
Cheon, D. Y. [1 ]
Kim, S. A. [1 ]
机构：
[1] Hallym Univ, Sacred Heart Hosp, Anyang, South Korea
[2] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction
    Lee, Jae-Geun
    Joo, Seung-Jae
    Kim, Song-Yi
    Choi, Joon-Hyouk
    Boo, Ki Yung
    Hwang, Jin-Yong
    Hur, Seung-Ho
    Jeong, Myung Ho
    Behalf KAMIR NIH Investigators
    PLOS BIOLOGY, 2023, 21 (03)
  • [32] Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)
    Mustafic, Hazrije
    Fayssoil, Abdallah
    Josseran, Loic
    Ouadahi, Mounir
    Grimaldi-Bensouda, Lamiae
    Dubourg, Olivier
    Annane, Djillali
    Mansencal, Nicolas
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 147 : 58 - 60
  • [33] Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With the Risk of Hospitalization and Death in Hypertensive Patients With COVID-19
    Khera, Rohan
    Clark, Callahan
    Lu, Yuan
    Guo, Yinglong
    Ren, Sheng
    Truax, Brandon
    Spatz, Erica S.
    Murugiah, Karthik
    Lin, Zhenqiu
    Omer, Saad B.
    Vojta, Deneen
    Krumholz, Harlan M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (13):
  • [34] Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)
    Mustafic, Hazrije
    Fayssoil, Abdallah
    Josseran, Loic
    Ouadahi, Mounir
    Grimaldi-Bensouda, Lamiae
    Dubourg, Olivier
    Annane, Djillali
    Mansencal, Nicolas
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 147 : 58 - 60
  • [35] Update Alert 10: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
    Mackey, Katherine
    Kansagara, Devan
    Vela, Kathryn
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (05)
  • [36] Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study
    Alexandre, Joachim
    Cracowski, Jean-Luc
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 (01) : 192 - 193
  • [37] Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors - Reply
    Wright, JT
    Davis, BR
    Cutler, JA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16): : 2069 - 2070
  • [38] Angiotensin receptor blockers, compared with angiotensin-converting enzyme inhibitors, increased recurrent myocardial infarction in hypertensive patients with acute myocardial infarction
    Joo, S. -J.
    Lee, J. -G.
    Boo, K. -Y.
    Choi, J. -H.
    Kim, S. -Y.
    Kim, K. -S.
    Rha, S. -W.
    Jeong, M. -H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1365 - 1366
  • [39] Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis
    Chen, Fu-An
    Chien, Chih-Chiang
    Chen, Yu-Wei
    Wu, Yu-Te
    Lin, Chih-Ching
    PLOS ONE, 2016, 11 (11):
  • [40] CARDIAC EVENTS OCCURRING DURING THE COURSE OF THE USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS/ANGIOTENSIN-RECEPTOR BLOCKERS IN FABRY DISEASE PATIENTS RECEIVING ENZYME REPLACEMENT THERAPY
    Warnock, D. C.
    CLINICAL THERAPEUTICS, 2008, 30 : S110 - S111
12345